RFG Advisory’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $478K | Buy |
2,186
+288
| +15% | +$63K | 0.01% | 646 |
|
|
2025
Q1 | $425K | Buy |
1,898
+219
| +13% | +$49K | 0.01% | 612 |
|
|
2024
Q4 | $550K | Buy |
1,679
+15
| +0.9% | +$4.91K | 0.02% | 499 |
|
|
2024
Q3 | $500K | Buy |
1,664
+165
| +11% | +$49.5K | 0.02% | 518 |
|
|
2024
Q2 | $494K | Buy |
1,499
+34
| +2% | +$11.2K | 0.02% | 502 |
|
|
2024
Q1 | $580K | Buy |
1,465
+33
| +2% | +$13.1K | 0.02% | 476 |
|
|
2023
Q4 | $504K | Sell |
1,432
-29
| -2% | -$10.2K | 0.02% | 444 |
|
|
2023
Q3 | $548K | Buy |
1,461
+20
| +1% | +$7.51K | 0.02% | 391 |
|
|
2023
Q2 | $551K | Buy |
1,441
+259
| +22% | +$99.1K | 0.02% | 402 |
|
|
2023
Q1 | $410K | Buy |
1,182
+26
| +2% | +$9.01K | 0.02% | 451 |
|
|
2022
Q4 | $316K | Buy |
1,156
+86
| +8% | +$23.5K | 0.02% | 504 |
|
|
2022
Q3 | $240K | Buy |
1,070
+64
| +6% | +$14.4K | 0.01% | 547 |
|
|
2022
Q2 | $344K | Sell |
1,006
-122
| -11% | -$41.7K | 0.02% | 436 |
|
|
2022
Q1 | $463K | Sell |
1,128
-217
| -16% | -$89.1K | 0.03% | 341 |
|
|
2021
Q4 | $631K | Sell |
1,345
-27
| -2% | -$12.7K | 0.04% | 263 |
|
|
2021
Q3 | $583K | Sell |
1,372
-69
| -5% | -$29.3K | 0.05% | 251 |
|
|
2021
Q2 | $518K | Sell |
1,441
-294
| -17% | -$106K | 0.05% | 263 |
|
|
2021
Q1 | $489K | Buy |
1,735
+19
| +1% | +$5.36K | 0.05% | 256 |
|
|
2020
Q4 | $528K | Sell |
1,716
-5
| -0.3% | -$1.54K | 0.07% | 232 |
|
|
2020
Q3 | $473K | Buy |
1,721
+210
| +14% | +$57.7K | 0.07% | 239 |
|
|
2020
Q2 | $343K | Buy |
1,511
+176
| +13% | +$40K | 0.05% | 261 |
|
|
2020
Q1 | $203K | Buy |
+1,335
| New | +$203K | 0.04% | 323 |
|